NUVL (STOCKS)
Nuvalent, Inc. Class A Common Stock
$103.690000
+0.950000 (+0.92%)
Prev close: $102.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- James R. Porter
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8,155.73M
- Employees
- 218
- P/E (TTM)
- -17.72
- P/B (TTM)
- 6.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
15
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.58 | $-1.51 | -0.0749 | -4.98% |
|
Sep 2025 (Q3)
|
$-1.70 | $-1.40 | -0.2994 | -21.38% |
|
Jun 2025 (Q2)
|
$-1.39 | $-1.26 | -0.1302 | -10.34% |
|
Mar 2025 (Q1)
|
$-1.18 | $-1.11 | -0.0728 | -6.58% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$10.49M |
| Operating Expenses | $414.31M |
| Research and Development | $306.97M |
| Other Operating Expenses | $107.34M |
| Operating Income/Loss | -$414.31M |
| Income/Loss From Continuing Operations After Tax | -$425.38M |
| Income/Loss From Continuing Operations Before Tax | -$424.79M |
| Income Tax Expense/Benefit | $585.00K |
| Net Income/Loss | -$425.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$425.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$425.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.85 |
| Diluted Earnings Per Share | -$5.85 |
| Basic Average Shares | 72,686,749 |
| Diluted Average Shares | 72,686,749 |
| Assets | $1.41B |
| Current Assets | $1.39B |
| Noncurrent Assets | $20.28M |
| Liabilities | $164.37M |
| Current Liabilities | $91.17M |
| Accounts Payable | $30.16M |
| Wages | $16.94M |
| Other Current Liabilities | $44.08M |
| Noncurrent Liabilities | $73.20M |
| Equity | $1.25B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.25B |
| Liabilities And Equity | $1.41B |
| Net Cash Flow From Operating Activities | -$275.21M |
| Net Cash Flow From Operating Activities, Continuing | -$275.21M |
| Net Cash Flow From Investing Activities | -$124.08M |
| Net Cash Flow From Investing Activities, Continuing | -$124.08M |
| Net Cash Flow From Financing Activities | $515.34M |
| Net Cash Flow From Financing Activities, Continuing | $515.34M |
| Net Cash Flow | $116.05M |
| Net Cash Flow, Continuing | $116.05M |
| Comprehensive Income/Loss | -$422.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$422.97M |
| Other Comprehensive Income/Loss | $2.41M |